Kenneth A. Jamerson
Division of Cardiovascular Medicine
Ann Arbor
MI 48106
USA
Name/email consistency: high
- Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control. Jamerson, K.A., Devereux, R., Bakris, G.L., Dahlöf, B., Pitt, B., Velazquez, E.J., Weir, M., Kelly, R.Y., Hua, T.A., Hester, A., Weber, M.A. Hypertension (2011)
- Prompt, aggressive BP lowering in high-risk patients. Jamerson, K.A., Basile, J. J. Clin. Hypertens. (Greenwich) (2008)
- Exceptional early blood pressure control rates: the ACCOMPLISH trial. Jamerson, K., Bakris, G.L., Dahlöf, B., Pitt, B., Velazquez, E., Gupte, J., Lefkowitz, M., Hester, A., Shi, V., Kjeldsen, S.E., Cushman, W., Papademetriou, V., Weber, M. Blood Press. (2007)
- Preventing chronic kidney disease in special populations. Jamerson, K.A. Am. J. Hypertens. (2005)
- The disproportionate impact of hypertensive cardiovascular disease in African Americans: getting to the heart of the issue. Jamerson, K.A. J. Clin. Hypertens. (Greenwich) (2004)
- Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson, K.A., Nwose, O., Jean-Louis, L., Schofield, L., Purkayastha, D., Baron, M. Am. J. Hypertens. (2004)
- The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH). Jamerson, K.A. J. Clin. Hypertens. (Greenwich) (2003)
- Rationale for angiotensin II receptor blockers in patients with low-renin hypertension. Jamerson, K.A. Am. J. Kidney Dis. (2000)